MIPS - Quality Measures - Allergen Immunotherapy Treatment: Allergen Specific Immunoglobulin E (IgE) Sensitivity Assessed and Documented Prior to Treatment
Percentage of patients aged 5 years and older who were assessed for IgE sensitivity to allergens prior to initiating allergen immunotherapy AND results documented in the medical record.National Quality Strategy Domain: Patient Safety Process Measure
eMeasure ID
First Performance Year
2017
Last Performance Year
Metric Type
Single Performance Rate
National Quality Strategy Domain
Patient Safety
Measure Type
Process
eMeasure UUID
NQF eMeasure ID
NQF ID
Is High Priority?
Is Inverse?
Overall Algorithm
Primary Steward
AAAAI American Academy of Allergy, Asthma, and Immunology Quality Clinical Data Registry Powered by Premier, Inc.